Stock ATHXQ ATHERSYS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Athersys, Inc.

Equities

ATHXQ

US04744L2051

Market Closed - OTC Markets
Other stock markets
 03:55:31 2024-05-06 pm EDT 		5-day change 1st Jan Change
0.0045 USD +4.65% Intraday chart for Athersys, Inc. +25.00% -77.50%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Apr. 05 Athersys, Inc. Announces Board Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge
DJ
Athersys : Acquisition/Asset Disposal - Form 8-K
PU
Athersys, Inc. Announces Board Changes
CI
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP
MT
North American Morning Briefing : Focus Turns to -2-
DJ
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .
CI
Final DIP Financing Approved for Athersys, Inc.
CI
Bidding Procedure Approved for Athersys, Inc.
CI
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal
MT
Interim DIP Financing Approved for Athersys, Inc.
CI
Motion for Joint Administration Approved for Athersys, Inc.
CI
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy
MT
Motion for Asset Sale Filed by Athersys, Inc.
CI
Motion for Joint Administration Filed by Athersys, Inc.
CI
Athersys, Inc. Filed for Bankruptcy
CI
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.
CI
Athersys, Inc. Announces Termination of Maia Hansen as Chief Operating Officer, Effective from December 31, 2023
CI
Athersys, Inc. Announces Termination of Daniel A. Camardo as Chief Executive Officer, Effective from December 31, 2023
CI
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
AQ
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATHXQ Stock
  4. News Athersys, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW